METHODS: A total of 14,834 and 108,399 patients with NENs were extracted from NCRAS and SEER, respectively. Sixty-months survival for both males and females for each anatomical site of NENs were calculated using restricted mean survival time (RMST) and Kaplan-Meier Survival estimates. The sixty-month RMST female survival advantage (FSA) was calculated.
RESULTS: FSA was similar in NCRAS and SEER. The highest FSA occurred in lung and stomach NENs.
CONCLUSIONS: The data from SEER confirm the findings published by NCRAS. Female survival advantage remains unexplained.
方法:从NCRAS和SEER中提取了14,834和108,399例NENs患者,分别。使用限制平均生存时间(RMST)和Kaplan-Meier生存估计值计算NEN每个解剖部位的男性和女性的60个月生存率。计算60个月RMST女性生存优势(FSA)。
结果:FSA在NCRAS和SEER中相似。FSA最高发生在肺和胃NENs。
结论:来自SEER的数据证实了NCRAS发表的研究结果。女性生存优势仍然无法解释。